share_log

金斯瑞生物科技(01548.HK):传奇生物发布首份ESG报告

Kingsley Biotech (01548.HK): Legendary Biotech Releases First ESG Report

Gelonghui Finance ·  Mar 19 08:46

Gelonghui March 19 | Kingsley Biotechnology (01548.HK) announced that Legend Biotechnology Co., Ltd. (a non-wholly-owned subsidiary of the company) released its first Environmental, Social and Governance (ESG) report on March 19, 2024.

The ESG report provides an overview of Legend Biotech's ESG plans and reports that meet the Sustainable Accounting Standards Committee's biotechnology and pharmaceutical industry standards, Legend Biotech's ESG data collection and disclosure roadmap, and future growth areas of its ESG path. The ESG report highlights Legendary Biotech's commitment to patients, employees, and communities, and marks a fundamental step on the ESG path and looks forward to continuing in the next few years.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment